To continue reading this article, sign up for FREE to
Membership is FREE
and provides you with
instant access
to email newsletters, digital publications, our full content catalogue & more...
Already have an account?
Aethlon Medical Establishes Sepsis & Inflammation Scientific Advisory Board
Read time: Less than a minute
The new therapeutics include a device to reduce the incidence of sepsis in combat-injured soldiers, which is being advanced under a contract from the Defense Advanced Research Projects Agency (DARPA). The initial members of the Aethlon Sepsis & Inflammation Scientific Advisory Board are Irshad Chaudry, Ph.D., Charles J. Fisher, Jr., MD and Geert Schmid-Schonbein, Ph.D.
Add Technology Networks as a preferred Google source to see more of our trusted coverage.
